Considerations on Regulation of Gene Therapy for Hemophilia

Gene Therapy in Hemophilia: Common Concerns in Gene TherapyПодробнее

Hemophilia Gene Therapies: Current Clinical Considerations and What’s Coming NextПодробнее

Gene Therapy for HemophiliaПодробнее

Current hurdles in AAV-based gene therapy for hemophiliaПодробнее

Six Shibboleths about Ethical Issues in Gene Therapy for HemophiliaПодробнее

Gene Therapy in HemophiliaПодробнее

Gene Therapy Basics for Hemophilia: What You Need to KnowПодробнее

Regulatory considerations for Cell and Gene Therapies - Jim DeKloeПодробнее

Safety of Gene Therapy for Hemophilia: Now and in the FutureПодробнее

Congressional Briefing: How Gene Therapies are Transforming the Hemophilia LandscapeПодробнее

2021 Conference on Gene Therapy for Rare Disorders - Factor VIII gene replacement for Hemophilia AПодробнее

ASGCT and HFA Webinar Series Gene Therapy in Bleeding Disorders – HemophiliaПодробнее

Preparing for Practice Readiness in Gene Therapy for HemophiliaПодробнее

Gene Therapy for Haemophilia: What, Why, How, When, Who, and Where?Подробнее

Gene Therapy – Target Factor Level and Other ConsiderationsПодробнее

AAV gene therapies for hemophilia A and BПодробнее

Gene Therapy for Treatment of Hemophilia: An Introduction to AAV Gene TransferПодробнее

Gene Therapy for Hemophilia: Progress and ConundrumsПодробнее

Hemophilia Gene Therapy- Key Components of Clinical CareПодробнее